<table frame="hsides" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 3. Efficacy Results from Phase 3 Studies of Patients with Early Breast Cancer*</caption>
<thead>
<tr><th align="left" valign="top"></th><th align="center" colspan="2" valign="top">MA-5 Study</th><th align="center" colspan="2" valign="top">GFEA-05 Study</th></tr>
<tr><td align="left" valign="top"></td><td align="center" valign="top">CEF-120</td><td align="center" valign="top">CMF</td><td align="center" valign="top">FEC-100</td><td align="center" valign="top">FEC-50</td></tr>
<tr><td align="left" valign="top"></td><td align="center" valign="top">N=356</td><td align="center" valign="top">N=356</td><td align="center" valign="top">N=276</td><td align="center" valign="top">N=289</td></tr>
</thead>
<tfoot>
<tr><td align="left" colspan="5" valign="top">*Based on Kaplan-Meier estimates</td></tr>
<tr><td align="left" colspan="5" valign="top">**Patients in MA-5 were stratified by nodal status (1 to 3, 4 to 10, and &gt; 10 positive nodes), type of initial surgery (lumpectomy versus mastectomy), and by hormone receptor status (ER or PR positive (≥10 fmol), both negative (&lt;10 fmol), or unknown staus). Patients in GFEA-05 were stratified by nodal status (1 to 3, 4 to 10, and &gt; 10 positive nodes).</td></tr>
<tr><td align="left" colspan="5" valign="top"><sup>†</sup>Hazard ratio: CMF:CEF-120 in MA-5, FEC-50:FEC-100 in GFEA-05</td></tr>
</tfoot>
<tbody>
<tr><td align="left" valign="top"><content stylecode="bold">RFS at 5 yrs (%)</content></td><td align="center" valign="top">62</td><td align="center" valign="top">53</td><td align="center" valign="top">65</td><td align="center" valign="top">52</td></tr>
<tr><td align="left" valign="top">Hazard ratio<sup>†</sup></td><td align="center" colspan="2" valign="top">0.76</td><td align="center" colspan="2" valign="top">0.69</td></tr>
<tr><td align="left" valign="top">2-sided 95% CI</td><td align="center" colspan="2" valign="top">(0.60, 0.96)</td><td align="center" colspan="2" valign="top">(0.52,0.89)</td></tr>
<tr><td align="left" valign="top">Log-rank Test stratified**</td><td align="center" colspan="2" valign="top">(p = 0.013)</td><td align="center" colspan="2" valign="top">(p = 0.007)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">OS at 5 yrs (%)</content></td><td align="center" valign="top">77</td><td align="center" valign="top">70</td><td align="center" valign="top">76</td><td align="center" valign="top">65</td></tr>
<tr><td align="left" valign="top">Hazard ratio<sup>†</sup></td><td align="center" colspan="2" valign="top">0.71</td><td align="center" colspan="2" valign="top">0.69</td></tr>
<tr><td align="left" valign="top">2-sided 95% CI</td><td align="center" colspan="2" valign="top">(0.52, 0.98)</td><td align="center" colspan="2" valign="top">(0.51,0.92)</td></tr>
<tr><td align="left" rowspan="2" valign="top">Log-rank Test stratified**</td><td align="center" colspan="2" valign="top">(p = 0.043) </td><td align="center" colspan="2" valign="top">(p = 0.007)</td></tr>
<tr><td align="center" colspan="2" valign="top">(unstratified p = 0.13)</td><td align="center" colspan="2" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">RFS at 10 yrs (%)</content></td><td align="center" valign="top">51</td><td align="center" valign="top">44</td><td align="center" valign="top">49</td><td align="center" valign="top">43</td></tr>
<tr><td align="left" valign="top">Hazard ratio<sup>†</sup></td><td align="center" colspan="2" valign="top">0.78</td><td align="center" colspan="2" valign="top">0.78</td></tr>
<tr><td align="left" valign="top">2-sided 95% CI</td><td align="center" colspan="2" valign="top">(0.63, 0.95)</td><td align="center" colspan="2" valign="top">(0.62,0.99)</td></tr>
<tr><td align="left" rowspan="2" valign="top">Log-rank Test stratified**</td><td align="center" colspan="2" valign="top">(p = 0.017)</td><td align="center" colspan="2" valign="top">(p = 0.040)</td></tr>
<tr><td align="center" colspan="2" valign="top">(unstratified p = 0.023)</td><td align="center" colspan="2" valign="top">(unstratified p = 0.09)</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">OS at 10 yrs (%)</content></td><td align="center" valign="top">61</td><td align="center" valign="top">57</td><td align="center" valign="top">56</td><td align="center" valign="top">50</td></tr>
<tr><td align="left" valign="top">Hazard ratio</td><td align="center" colspan="2" valign="top">0.82</td><td align="center" colspan="2" valign="top">0.75</td></tr>
<tr><td align="left" valign="top">2-sided 95% CI</td><td align="center" colspan="2" valign="top">(0.65, 1.04)</td><td align="center" colspan="2" valign="top">(0.58,0.96)</td></tr>
<tr><td align="left" valign="top">Log-rank Test stratified**</td><td align="center" colspan="2" valign="top">(p = 0.100) </td><td align="center" colspan="2" valign="top">(p = 0.023)</td></tr>
<tr><td align="left" valign="top"></td><td align="center" colspan="2" valign="top">(unstratified p = 0.18)</td><td align="center" colspan="2" valign="top">(unstratified p = 0.039)</td></tr>
</tbody>
</table>